Edwards Lifesciences (EW) Non-Current Debt (2016 - 2025)
Edwards Lifesciences (EW) has 17 years of Non-Current Debt data on record, last reported at $598.3 million in Q4 2025.
- For Q4 2025, Non-Current Debt changed 0.1% year-over-year to $598.3 million; the TTM value through Dec 2025 reached $598.3 million, changed 0.1%, while the annual FY2025 figure was $598.3 million, 0.1% changed from the prior year.
- Non-Current Debt reached $598.3 million in Q4 2025 per EW's latest filing, roughly flat from $598.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $598.3 million in Q4 2025 and bottomed at $595.2 million in Q1 2021.
- Average Non-Current Debt over 5 years is $596.8 million, with a median of $596.8 million recorded in 2023.
- Peak YoY movement for Non-Current Debt: rose 0.12% in 2021, then rose 0.1% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $595.7 million in 2021, then rose by 0.1% to $596.3 million in 2022, then increased by 0.12% to $597.0 million in 2023, then grew by 0.12% to $597.7 million in 2024, then increased by 0.1% to $598.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Non-Current Debt were $598.3 million in Q4 2025, $598.2 million in Q3 2025, and $598.0 million in Q2 2025.